Intragastric Balloon Market Opportunity, Demand, Recent trends, Major Driving Factors 2028

Page 1

Intragastric Balloon Market Size Analysis, Trends, Top Manufacturers, Share, Growth, Statistics, Opportunities and Forecast to 2028 Global Market Insights recently added a detailed market research study focused on the Global Intragastric Balloon Market across the global, regional and country level. The report provides 360° analysis of Intragastric Balloon Market from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Intragastric Balloon market and estimates the future trend of Global Intragastric Balloon industry on the basis of this detailed study. Get sample copy of this research report @ https://www.gminsights.com/requestsample/detail/1173 The intragastric balloon market is projected to expand substantially by 2028 on account of rising adoption of minimally invasive treatment techniques in leading regions. The COVID-19 pandemic-induced lockdown forced people out of their regular routines and into lower levels of physical activity, poor diet, and overeating, which resulted in a spike in the prevalence of obesity. As a result, mounting incidences of obesity and increasing preference of obese patients towards minimally invasive methods of treatment have augmented industry uptake in recent years. Furthermore, industry participants have been focusing on product innovation and development to gain a competitive edge in evolving marketplaces, which has favorably impacted overall business dynamics. For instance, in March 2021, Apollo Endosurgery, Inc., a global provider of minimally invasive therapies, received the U.S. FDA approval for its novel intragastric balloon for treating patients with NASH (non-alcoholic steatohepatitis) dubbed the Orbera® Intragastric Balloon. To cite another instance, in November 2021, ReShape Lifesciences Inc., a leading manufacturer of minimally invasive medical devices to treat metabolic disease and obesity, launched ProCare Health Supplements. The novel line of supplements is intended to meet the nutritional needs of patients who have undergone medical weight-loss treatment and bariatric surgery. The intragastric balloon market has been segmented on the basis of end-use, product, filling material, and region. With respect to product, the market has further been classified into triple intragastric balloon, single intragastric balloon, and dual intragastric balloon. The single intragastric balloon sub-segment is slated to progress at a considerable CAGR over the analysis period to reach around USD 35.6 million valuation by the end of 2028. In terms of filling material, the intragastric balloon market has been bifurcated into salinefilled balloon and gas-filled balloon. In 2021, the gas-filled balloon sub-segment was valued at nearly USD 12.4 million and is primed to grow at a sturdy pace through the assessment timeline. © 2022 Global Market Insights Inc. All Rights Reserved

www.gminsights.com


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.